Cargando…

METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10

OBJECTIVE: N6-methyladenosine (m6A) RNA methylation is involved in governing the mechanism of tumor progression. We aimed to excavate the biological role and mechanism of the m6A methyltransferase METTL3 in cholangiocarcinoma (CCA). METHODS: METTL3 expression was determined by database and tissue mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Jingli, Cui, Zheng, Zhou, Jingyi, Zhang, Bosen, Lu, Ruiqi, Ding, Youcheng, Hu, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730622/ https://www.ncbi.nlm.nih.gov/pubmed/36476503 http://dx.doi.org/10.1186/s12935-022-02809-2

Ejemplares similares

IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization
por: Qin, Jian, et al.
Publicado: (2023)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3
por: Yi, Jianmei, et al.
Publicado: (2023)

Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
por: van Weverwijk, Antoinette, et al.
Publicado: (2019)

Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
por: Wu, Tiangen, et al.
Publicado: (2021)

Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification is required for cerebellar development
por: Wang, Chen-Xin, et al.
Publicado: (2018)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
por: Zhou, Xinying, et al.
Publicado: (2022)

METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner
por: Xu, Qiong-Cong, et al.
Publicado: (2022)

METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m(6)A Modification
por: Hu, Shaojun, et al.
Publicado: (2022)

Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification
por: Zhou, Xinying, et al.
Publicado: (2023)

The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)

METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
por: Wang, Xiaotong, et al.
Publicado: (2023)

METTL3-mediated m(6)A modification regulates cell cycle progression of dental pulp stem cells
por: Luo, Haiyun, et al.
Publicado: (2021)

Retracted: METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m(6)A Modification
por: Healthcare Engineering, Journal of
Publicado: (2023)

METTL3-dependent m(6)A modification programs T follicular helper cell differentiation
por: Yao, Yingpeng, et al.
Publicado: (2021)

METTL14-dependent m(6)A modification controls iNKT cell development and function
por: Cao, Liang, et al.
Publicado: (2022)

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer
por: Zhu, Miaohua, et al.
Publicado: (2022)

METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021)

METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2021)

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression
por: Li, Zhi, et al.
Publicado: (2021)

Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer
por: Sun, Lianhui, et al.
Publicado: (2023)

METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
por: Hou, Yichao, et al.
Publicado: (2023)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021)

Mettl3-dependent m(6)A modification attenuates the brain stress response in Drosophila
por: Perlegos, Alexandra E., et al.
Publicado: (2022)

METTL3-mediated m(6)A modification stabilizes TERRA and maintains telomere stability
por: Chen, Liping, et al.
Publicado: (2022)

METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma
por: Wu, Yingtong, et al.
Publicado: (2021)

METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021)

Fusobacterium nucleatum reduces METTL3-mediated m(6)A modification and contributes to colorectal cancer metastasis
por: Chen,, Shujie, et al.
Publicado: (2022)

AKR1B10 regulates M2 macrophage polarization to promote the malignant phenotype of gastric cancer
por: Wu, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h89ki085o7b0ut87q9mv97k9av